Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Nita Lee

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentObstetrics & Gynecology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Nita Karnik Lee, MD, specializes in the diagnosis and treatment of women with gynecologic malignancies. Her focus is on providing comprehensive and compassionate care to women diagnosed with ovarian, uterine, cervical, vulvar or vaginal cancers. She is skilled in minimally invasive surgical techniques, including robotic surgery for gynecologic cancers and complex benign gynecologic conditions.

    Dr. Lee’s research interests include cancer survivorship, cancer disparities, and clinical trials focusing on new therapies for ovarian, uterine and cervical cancers. She is an active member of the Gynecologic Oncology Group (GOG), a cooperative research group supported by the National Cancer Institute.

    Her recent funded research focuses on endometrial cancer survivorship and the importance of healthy lifestyle change after diagnosis. She is also interested in the screening, prevention, and early detection of gynecologic cancers by educating providers and patients.


    Collapse Biography 
    Collapse education and training
    Tulane UniversityMD
    Northwestern Memorial HospitalInternship
    Northwestern Memorial HospitalResidency
    University of California, San Francisco; Stanford University HospitalFellowship

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, Tatebe K, Veneris JL. Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 2019 Jul; 69(4):258-279. PMID: 31074865.
      View in: PubMed
    2. Hoppenot C, Peters P, Cowan M, Moore ED, Hurteau J, Lee NK, Yamada SD. Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome? Gynecol Oncol. 2019 Jul; 154(1):177-182. PMID: 31056111.
      View in: PubMed
    3. Ross JGC, Escamilla V, Lee NK, Diane Yamada S, Lindau ST. Geospatial patterns of access to self-care resources for obesity among endometrial cancer survivors in a high poverty urban community. Gynecol Oncol. 2019 02; 152(2):322-327. PMID: 30581035.
      View in: PubMed
    4. Kim JS, Mills KA, Fehniger J, Liao C, Hurteau JA, Kirschner CV, Lee NK, Rodriguez GC, Yamada SD, Diaz Moore ES, Tenney ME. Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer. Int J Gynecol Cancer. 2017 10; 27(8):1774-1782. PMID: 28708786.
      View in: PubMed
    5. Feng CH, Miller CM, Tenney ME, Lee NK, Yamada SD, Hasan Y. Statin Use Significantly Improves Overall Survival in High-Grade Endometrial Cancer. Int J Gynecol Cancer. 2016 11; 26(9):1642-1649. PMID: 27654261.
      View in: PubMed
    6. Sampat A, Parakati I, Kunnavakkam R, Glick DB, Lee NK, Tenney M, Eggener S, Roth S. Corneal abrasion in hysterectomy and prostatectomy: role of laparoscopic and robotic assistance. Anesthesiology. 2015 May; 122(5):994-1001. PMID: 25734923.
      View in: PubMed
    7. Hunn J, Tenney ME, Tergas AI, Bishop EA, Moore K, Watkin W, Kirschner C, Hurteau J, Rodriguez GC, Lengyel E, Lee NK, Yamada SD. Patterns and utility of routine surveillance in high grade endometrial cancer. Gynecol Oncol. 2015 Jun; 137(3):485-9. PMID: 25838164.
      View in: PubMed
    8. Kennedy V, Abramsohn E, Makelarski J, Barber R, Wroblewski K, Tenney M, Lee NK, Yamada SD, Lindau ST. Can you ask? We just did! Assessing sexual function and concerns in patients presenting for initial gynecologic oncology consultation. Gynecol Oncol. 2015 Apr; 137(1):119-24. PMID: 25582823.
      View in: PubMed
    9. Buell-Gutbrod R, Cavallo A, Lee N, Montag A, Gwin K. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma. Int J Gynecol Pathol. 2015 Jan; 34(1):65-73. PMID: 25473755.
      View in: PubMed
    10. Matulonis UA, Lee J, Lasonde B, Tew WP, Yehwalashet A, Matei D, Behbakht K, Grothusen J, Fleming G, Lee NK, Arnott J, Bray MR, Fletcher G, Brokx RD, Castonguay V, Mackay H, Sidor CF, Oza AM. ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer. Eur J Cancer. 2013 Jan; 49(1):121-31. PMID: 22921155.
      View in: PubMed
    11. Song S, Rudra S, Hasselle MD, Dorn PL, Mell LK, Mundt AJ, Yamada SD, Lee NK, Hasan Y. The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy. Cancer. 2013 Jan 15; 119(2):325-31. PMID: 22806897.
      View in: PubMed
    12. Lee NK. Adjuvant treatment of advanced-stage endometrial cancer. Clin Obstet Gynecol. 2011 Jun; 54(2):256-65. PMID: 21508695.
      View in: PubMed
    13. Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Kapp DS, Osann K, Chan JK. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007 Mar; 109(3):655-62. PMID: 17329517.
      View in: PubMed
    Lee's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _